Anne-Christine Bay-Jensen

Publications

• Biochemical Markers in Osteoarthritis with Lessons Learned from Osteoporosis
  Clinical and Experimental Rheumatology. Sep-Oct, 2019  |   Pubmed ID: 31621570
• Associations Between Biomarkers of Bone and Cartilage Turnover, Gender, Pain Categories and Radiographic Severity in Knee Osteoarthritis
  Arthritis Research & Therapy. Sep, 2019  |   Pubmed ID: 31481084
• Serological Assessment of the Quality of Wound Healing Processes in Crohn's Disease
  Journal of Gastrointestinal and Liver Diseases : JGLD. Jun, 2019  |   Pubmed ID: 31204415
• Osteoarthritis Phenotypes and Novel Therapeutic Targets
  Biochemical Pharmacology. Jul, 2019  |   Pubmed ID: 30831073
• Association of Metabolites Reflecting Type III and VI Collagen Formation with Modified Rodnan Skin Score in Systemic Sclerosis - a Cross-sectional Study
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. Jun, 2019  |   Pubmed ID: 30821519
• GPDPLQ-A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in Vitro
  Scientific Reports. Feb, 2019  |   Pubmed ID: 30816326
• Metabolites of C-reactive Protein and Vimentin Are Associated with Disease Activity of Axial Spondyloarthritis
  Clinical and Experimental Rheumatology. May-Jun, 2019  |   Pubmed ID: 30767876
• Serological Biomarker Profiles of Rapidly Progressive Osteoarthritis in Tanezumab-treated Patients
  Osteoarthritis and Cartilage. Mar, 2019  |   Pubmed ID: 30576794
• Osteoarthritis Year in Review 2018: Biomarkers (biochemical Markers)
  Osteoarthritis and Cartilage. Mar, 2019  |   Pubmed ID: 30552966
• Molecular Taxonomy of Osteoarthritis for Patient Stratification, Disease Management and Drug Development: Biochemical Markers Associated with Emerging Clinical Phenotypes and Molecular Endotypes
  Current Opinion in Rheumatology. 01, 2019  |   Pubmed ID: 30461544
• The VICM Biomarker is Released from Activated Macrophages and Inhibited by Anti-GM-CSFRα-mAb Treatment in Rheumatoid Arthritis Patients
  Clinical and Experimental Rheumatology. Jan-Feb, 2019  |   Pubmed ID: 30418117
• Tofacitinib and TPCA-1 Exert Chondroprotective Effects on Extracellular Matrix Turnover in Bovine Articular Cartilage Ex Vivo
  Biochemical Pharmacology. Jul, 2019  |   Pubmed ID: 30059674
• Bone and Soft Tissue Turnover in Relation to All-cause Mortality in Postmenopausal Women
  The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. Jun, 2019  |   Pubmed ID: 30010805
• Protein Biomarkers Associated with Pain Mechanisms in Osteoarthritis
  Journal of Proteomics. 01, 2019  |   Pubmed ID: 29704569
• Changes of Patient-reported Outcomes and Protein Fingerprint Biomarkers After Exercise Therapy for Axial Spondyloarthritis
  Clinical Rheumatology. Jan, 2019  |   Pubmed ID: 28856518
• Serum Biomarkers of Collagen Turnover As Potential Diagnostic Tools in Diffuse Systemic Sclerosis: A Cross-sectional Study
  PloS One. 2018  |   Pubmed ID: 30507931
• A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation
  International Journal of Molecular Sciences. Nov, 2018  |   Pubmed ID: 30404167
• Type IV Collagen Metabolism is Associated with Disease Activity, Radiographic Progression and Response to Tocilizumab in Rheumatoid Arthritis
  Clinical and Experimental Rheumatology. Sep-Oct, 2018  |   Pubmed ID: 29745884
• Aggrecanase Degradation of Type III Collagen is Associated with Clinical Knee Pain
  Clinical Biochemistry. Aug, 2018  |   Pubmed ID: 29702061
• Increased Remodelling of Interstitial Collagens and Basement Membrane is Suppressed by Treatment in Patients with Rheumatoid Arthritis: Serological Evaluation of a One-year Prospective Study of 149 Japanese Patients
  Clinical and Experimental Rheumatology. May-Jun, 2018  |   Pubmed ID: 29465351
• IL-6 Receptor Inhibition Modulates Type III Collagen and C-reactive Protein Degradation in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-tumour Necrosis Factor Therapy: Analysis of Connective Tissue Turnover in the Tocilizumab RADIATE Study
  Clinical and Experimental Rheumatology. Jul-Aug, 2018  |   Pubmed ID: 29465346
• Identification of Pain Categories Associated with Change in Pain in Patients Receiving Placebo: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee Osteoarthritis
  BMC Musculoskeletal Disorders. 01, 2018  |   Pubmed ID: 29343266
• Blockade of GM-CSF Pathway Induced Sustained Suppression of Myeloid and T Cell Activities in Rheumatoid Arthritis
  Rheumatology (Oxford, England). 01, 2018  |   Pubmed ID: 29069507
• Biochemical Marker Discovery, Testing and Evaluation for Facilitating OA Drug Discovery and Development
  Drug Discovery Today. 02, 2018  |   Pubmed ID: 29038075
• Suppression of Active, but Not Total MMP-3, is Associated with Treatment Response in a Phase III Clinical Study of Rheumatoid Arthritis
  Clinical and Experimental Rheumatology. Jan-Feb, 2018  |   Pubmed ID: 28850021
• Soluble Biochemical Markers of Osteoarthritis: Are We Close to Using Them in Clinical Practice?
  Best Practice & Research. Clinical Rheumatology. 10, 2017  |   Pubmed ID: 30509415
• Sprifermin (rhFGF18) Modulates Extracellular Matrix Turnover in Cartilage Explants Ex Vivo
  Journal of Translational Medicine. Dec, 2017  |   Pubmed ID: 29233174
• Ulcerative Colitis, Crohn's Disease, and Irritable Bowel Syndrome Have Different Profiles of Extracellular Matrix Turnover, Which Also Reflects Disease Activity in Crohn's Disease
  PloS One. 2017  |   Pubmed ID: 29028807
• Excessive Matrix Metalloprotease-mediated Degradation of Interstitial Tissue (type I Collagen) Independently Predicts Short-term Survival in an Observational Study of Postmenopausal Women Diagnosed with Cancer
  Oncotarget. Aug, 2017  |   Pubmed ID: 28881747
• Unique Insight into Microenvironmental Changes in Colorectal Cancer: Assessment of Matrix Metalloprotease-mediated Molecular Changes in Human Colorectal Tumor Tissue and Corresponding Non-neoplastic Adjacent Tissue
  Oncology Letters. May, 2017  |   Pubmed ID: 28529592
• Biomarker of Extracellular Matrix Remodelling C1M and Proinflammatory Cytokine Interleukin 6 Are Related to Synovitis and Pain in End-stage Knee Osteoarthritis Patients
  Pain. 07, 2017  |   Pubmed ID: 28333699
• Nidogen-1 Degraded by Cathepsin S Can Be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer
  Neoplasia (New York, N.Y.). 04, 2017  |   Pubmed ID: 28282545
• Type I and III Collagen Turnover is Increased in Axial Spondyloarthritis and Psoriatic Arthritis. Associations with Disease Activity and Diagnostic Capacity
  Clinical and Experimental Rheumatology. Jul-Aug, 2017  |   Pubmed ID: 28240584
• Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study
  Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 09, 2016  |   Pubmed ID: 27411352
• Chondrocyte Activity is Increased in Psoriatic Arthritis and Axial Spondyloarthritis
  Arthritis Research & Therapy. 06, 2016  |   Pubmed ID: 27306080
• Intercritical Circulating Levels of Neo-epitopes Reflecting Matrixmetalloprotease-driven Degradation As Markers of Gout and Frequent Gout Attacks
  Rheumatology (Oxford, England). 09, 2016  |   Pubmed ID: 27256715
• Neo-Epitopes--Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis
  PloS One. 2016  |   Pubmed ID: 27019199
• Synovitis Biomarkers: Ex Vivo Characterization of Three Biomarkers for Identification of Inflammatory Osteoarthritis
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 2015  |   Pubmed ID: 26863055
• Serum Cartilage Oligomeric Matrix Protein and Development of Radiographic and Painful Knee Osteoarthritis. A Community-based Cohort of Middle-aged Women
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 2015  |   Pubmed ID: 26848781
• Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis
  Journal of Crohn's & Colitis. Oct, 2015  |   Pubmed ID: 26188349
• Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD
  Chest. Jul, 2015  |   Pubmed ID: 25856563
• Novel Insights into the Function and Dynamics of Extracellular Matrix in Liver Fibrosis
  American Journal of Physiology. Gastrointestinal and Liver Physiology. May, 2015  |   Pubmed ID: 25767261
• Cartilage Turnover Reflected by Metabolic Processing of Type II Collagen: a Novel Marker of Anabolic Function in Chondrocytes
  International Journal of Molecular Sciences. Oct, 2014  |   Pubmed ID: 25329619
• Serum Biomarkers Reflecting Specific Tumor Tissue Remodeling Processes Are Valuable Diagnostic Tools for Lung Cancer
  Cancer Medicine. Oct, 2014  |   Pubmed ID: 25044252
• The Active Form of MMP-3 is a Marker of Synovial Inflammation and Cartilage Turnover in Inflammatory Joint Diseases
  BMC Musculoskeletal Disorders. Mar, 2014  |   Pubmed ID: 24641725
• Rheumatoid Arthritis: a Case for Personalized Health Care?
  Arthritis Care & Research. Sep, 2014  |   Pubmed ID: 24470057
• Extracellular Matrix Specific Protein Fingerprints Measured in Serum Can Separate Pancreatic Cancer Patients from Healthy Controls
  BMC Cancer. Nov, 2013  |   Pubmed ID: 24261855
• Quantification of "end Products" of Tissue Destruction in Inflammation May Reflect Convergence of Cytokine and Signaling Pathways -- Implications for Modern Clinical Chemistry
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. Aug, 2013  |   Pubmed ID: 23721060
• Extracellular Matrix Remodeling: the Common Denominator in Connective Tissue Diseases. Possibilities for Evaluation and Current Understanding of the Matrix As More Than a Passive Architecture, but a Key Player in Tissue Failure
  Assay and Drug Development Technologies. Mar, 2013  |   Pubmed ID: 23046407
• Investigation of Chondrocyte Hypertrophy and Cartilage Calcification in a Full-depth Articular Cartilage Explants Model
  Rheumatology International. Feb, 2013  |   Pubmed ID: 22453523
• Future Detection and Monitoring of Diabetes May Entail Analysis of Both β-cell Function and Volume: How Markers of β-cell Loss May Assist
  Journal of Translational Medicine. Oct, 2012  |   Pubmed ID: 23110768
• The Inhibitory Effect of Salmon Calcitonin on Tri-iodothyronine Induction of Early Hypertrophy in Articular Cartilage
  PloS One. 2012  |   Pubmed ID: 22768225
• Characterization of an Ex Vivo Femoral Head Model Assessed by Markers of Bone and Cartilage Turnover
  Cartilage. Jul, 2011  |   Pubmed ID: 26069585
• Diagnosis of Osteoarthritis by Cartilage Surface Smoothness Quantified Automatically from Knee MRI
  Cartilage. Jan, 2011  |   Pubmed ID: 26069569
• Molecular Serum and Urine Marker Repertoire Supporting Clinical Research on Joint Diseases
  Best Practice & Research. Clinical Rheumatology. Dec, 2011  |   Pubmed ID: 22265266
• Glucocorticoids Exert Context-dependent Effects on Cells of the Joint in Vitro
  Steroids. Dec, 2011  |   Pubmed ID: 21855558
• Biochemical Markers of Ongoing Joint Damage in Rheumatoid Arthritis--current and Future Applications, Limitations and Opportunities
  Arthritis Research & Therapy. Apr, 2011  |   Pubmed ID: 21539724
• Measurement of Matrix Metalloproteinase 9-mediated Collagen Type III Degradation Fragment As a Marker of Skin Fibrosis
  BMC Dermatology. Mar, 2011  |   Pubmed ID: 21447148
• Enzyme-linked Immunosorbent Assay (ELISAs) for Metalloproteinase Derived Type II Collagen Neoepitope, CIIM--increased Serum CIIM in Subjects with Severe Radiographic Osteoarthritis
  Clinical Biochemistry. Apr, 2011  |   Pubmed ID: 21223960
• Oral Salmon Calcitonin--pharmacology in Osteoporosis
  Expert Opinion on Biological Therapy. Nov, 2010  |   Pubmed ID: 20932224
• Novel Combinations of Post-Translational Modification (PTM) Neo-epitopes Provide Tissue-specific Biochemical Markers--are They the Cause or the Consequence of the Disease?
  Clinical Biochemistry. Jul, 2010  |   Pubmed ID: 20381482
• Investigation of the Direct Effects of Salmon Calcitonin on Human Osteoarthritic Chondrocytes
  BMC Musculoskeletal Disorders. Apr, 2010  |   Pubmed ID: 20367884
• Procollagen Type I N-terminal Propeptide (PINP) is a Marker for Fibrogenesis in Bile Duct Ligation-induced Fibrosis in Rats
  Fibrogenesis & Tissue Repair. Apr, 2010  |   Pubmed ID: 20359335
• Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-epitope Approach in the Development of New Biomarkers
  Disease Markers. 2010  |   Pubmed ID: 20164543
• Application of Biochemical Markers in Development of Drugs for Treatment of Osteoarthritis
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. Feb, 2010  |   Pubmed ID: 20085489
• Aggrecanase- and Matrix Metalloproteinase-mediated Aggrecan Degradation is Associated with Different Molecular Characteristics of Aggrecan and Separated in Time Ex Vivo
  Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. May, 2010  |   Pubmed ID: 20039789
• Which Elements Are Involved in Reversible and Irreversible Cartilage Degradation in Osteoarthritis?
  Rheumatology International. Feb, 2010  |   Pubmed ID: 19816688
• Biochemical Markers of Joint Tissue Turnover
  Assay and Drug Development Technologies. Feb, 2010  |   Pubmed ID: 19715454
• Suppression of MMP Activity in Bovine Cartilage Explants Cultures Has Little if Any Effect on the Release of Aggrecanase-derived Aggrecan Fragments
  BMC Research Notes. Dec, 2009  |   Pubmed ID: 20021645
• The Disease Modifying Osteoarthritis Drug (DMOAD): Is It in the Horizon?
  Pharmacological Research. Jul, 2008  |   Pubmed ID: 18590824